3T Biosciences

3T Biosciences is solving major bottleneck in the field of immunotherapy - identifying novel targets that can be used to generate therapies to treat cancer in broad patient populations. We are developing transformative T cell receptor therapies for cancer and other immune-related diseases. Our proprietary experimental and computational technology allows us to identify novel T cell receptor targets as well as clinical toxicities to bring safe and effective therapies. 

Focus area
Other
Graduation date
10/27/2017
Commencement date
09/01/2017